Profile of Serogroup Y Meningococcal Infections in Canada: Implications for Vaccine Selection
Canada is a leader in establishing routine infant immunization programs against meningococcal C disease. Currently, all provinces have routine programs to provide meningococcal C conjugate vaccines to infants and children. The result of the existing programs has been a decrease in serogroup C incide...
Saved in:
Main Authors: | Nicole Le Saux, Julie A Bettinger, Susan Wootton, Scott A Halperin, Wendy Vaudry, David W Scheifele, Raymond Tsang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2009/871071 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Are Physicians Obligated to Tell Parents about the Meningococcal Serogroup B Vaccine?
by: Dr Joan L Robinson
Published: (2015-01-01) -
Characterization of Serogroup A Neisseria meningitidis from Invasive Meningococcal Disease Cases in Canada Between 1979 and 2006: Epidemiological Links to Returning Travellers
by: Angela M Sloan, et al.
Published: (2008-01-01) -
Potential Capsule Switching from Serogroup Y to B: The Characterization of Three such Neisseria meningitidis Isolates Causing Invasive Meningococcal Disease in Canada
by: Raymond SW Tsang, et al.
Published: (2005-01-01) -
Heterogeneity of Rotavirus Testing and Admitting Practices for Gastroenteritis among 12 Tertiary Care Pediatric Hospitals: Implications for Surveillance
by: Julie A. Bettinger, et al.
Published: (2011-01-01) -
Epidemiological Characteristics of Meningococcal Meningitis (2016 to 2018) Four Years after the Introduction of Serogroup A Meningococcal Conjugate Vaccine in Benin
by: Togbemabou Primous Martial Godjedo, et al.
Published: (2020-01-01)